The prostate cancer mortality rates call for dedication in identification, awareness and treatment of this disease. Most diagnoses are carried out when the cancer has already progressed to late stage 2, and such factors make it unfeasible to perform surgery. Patients are left with very limited treatment options of chemotherapy and radiotherapy. A new clinical trial has discovered a potential way of treating certain types of cancer if the method is successfully adopted. Here are facts of the study: • Known as the PRISM study, the clinical trial involves Prostate Radiotherapy Integrated with Simultaneous MRI study 1. Scientists are putting into practice a treatment machine that is highly accurate and can adjust its target in real time. This innovate approach will provider shorter treatment times with great success rates and fewer side effects. • Utilizing the MRI scan to locate cancer of the prostate shows the edge of the prostate more clearly and can also identify the area within the prostate that has the most aggressive cancer. The new machine combines a radiotherapy machine with an MR scanner. The new machine allows investigators to monitor the prostate while the patient is undergoing treatment and they can also change the radiotherapy plan if they see that the internal anatomy has shifted day to day. • This is the first technology to simultaneously generate magnetic resonance images while delivering X-ray radiation beams and allow radiotherapy to be delivered effectively with accuracy and be adjusted in real time. This ability to target tumors using radiation beams in real time will be effective particularly for those cancers that shift positions through breathing, bowel changes or bladder filling and will also reduce the side effects for the patient. • Prostate cancer is prevalent within many populations of the world, and most patients who are diagnosed are treated successfully and manage to survive ten years or longer. The high success rate in long-term survival outcome means that more focus should be placed on both the success of the treatment and the long-term side effects a patient should expect to endure from the treatment they receive. • Radiotherapy is among the main treatment approaches for prostate cancer where highly accurate beams of radiation are directed at the tumor. This procedure also affects a small surrounding area to ensure a great chance of destroying the cancer cells while minimizing the damage to the healthy tissue. The radiation beams do not distinguish between the tissues they hit, and it depends on the skill of the physician administering the treatment to ensure the damage to healthy tissue is minimized. Currently, radiotherapy treatment works with millimetre accuracy and requires planning and practice to ensure that the beams are aimed at the correct area. This treatment approach using radiotherapy is effective but can be improved. The most prevalent approach to planning a radiotherapy treatment for prostate cancer depends on planning a CT scan. The patient undergoes a CT scan of the prostate region to allow the planning staff to identify the size, shape and location of the prostate and create a treatment plan. The treatment will take up to 6 weeks of daily treatments based on the planning CT scan of the prostate
0 Comments
|
AuthorAs the founder and medical director of the Prostate Seed Institute Dr. Gregory A. Echt. His vision to provide the most modern treatment, non surgical treatments for prostate cancer in various locations throughout the Dallas-Fort Worth continues to succeed. Now date, he has made a therapy for prostate implantation seed at over 2,500 men, including urologists and oncologists. Archives
December 2019
Categories |